van der Baan Bastiaan Jeroen 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jul 18, 2022
Insider Transaction Report
Form 4
van der Baan Bastiaan Jeroen
Director
Transactions
- Award
Options to Purchase Common Stock
2022-06-17+250,000→ 250,000 totalExercise: $0.74From: 2022-06-17Exp: 2027-06-17→ Common (250,000 underlying)
Footnotes (1)
- [F1]In connection with the Reporting Person's appointment as a director of the Issuer, the Issuer granted to the Reporting Person options to purchase 250,000 shares of the Issuer's Common Stock exercisable for a period of five years at an exercise price of $0.74 vesting 50% on the date of the grant and the remaining 50% vesting 12.5% beginning in the quarter immediately subsequent to the date of the grant until fully vested, subject to continued service.